Welcome to the Edge Therapeutics’ “NEWTON 2” Study!
The BIOS team at Johns Hopkins University is delighted to be a part of Edge Therapeutics' clinical study NEWTON2 (Protocol EG-01-1962-03) evaluating a new treatment for certain patients with aneurysmal subarachnoid hemorrhage (aSAH). Our goal at BIOS will be to ensure that the blinded assessors at the clinical sites are well versed on the neurologic outcome assessments in this study. We are providing this online training course, assessment tools, and informational updates. Please see the menu for these materials.
Please contact the BIOS team with any questions. We look forward to working with you!